Although the partially controlled blood glucose subgroup showed an almost similar result (Table 4) where there was no reduction in CML and IL-1α activity in the CAo + CAt group on day 29, the SOD activity increased significantly higher than that of the other groups (p=0.03). The gene discussed is IL1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.